SciELO - Scientific Electronic Library Online

 
vol.22 número1PREVALENCIA DE VIRUS LINFOTRÓPICO HUMANO EN DONANTES DE SANGRE DEL HOSPITAL NACIONAL, PARAGUAYTERAPIA CELULAR PARA EL TRATAMIENTO DE ÚLCERAS CRÓNICAS índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Médica La Paz

versión On-line ISSN 1726-8958

Resumen

AMARU CALZADA, Ariel et al. FREQUENCY OF P210 BCR-ABL TRANSCRIPTS IN 272 BOLIVIAN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML). Rev. Méd. La Paz [online]. 2016, vol.22, n.1, pp. 13-19. ISSN 1726-8958.

There are two main forms of BCR/ABL fusion gene, involving exon 2 of ABL gene and different exons of the BCR gene, the transcripts b2a2 or b3a2 code for a p210 protein, and the transcript e1a2 code a p190 protein. In Bolivia, there is no information about the frequency of these isoforms of chimeric gene BCR/ABL in chronic myeloid leukemia (CML). The present study was designed to determine the frequency of co-expression of p210 transcripts in 272 patients with CML. It was conducted reverse transcriptase polymerase chain reaction (RT-PCR) tests in samples of bone marrow and peripheral blood of adult and pediatric patients with CML diagnosis, positive for some kind of BCR/ABL rearrangement. The transcript b2a2 was found in 96 (35,3%) patients; and b3a2 transcript in 154 (56.6%) cases; whereas, in 22 (8.1%) patients both transcripts were detected. Survival analysis was performed, it was observed that to 5 years the overall survival (OS) was 64%, and the progression free survival (PFS) was 42%. It was also observed that the type of transcript does not affect OS and PFS. Statistical analysis of our study, displayed no significant differences in the expression of different transcripts BCR/ABL of the Bolivian population, in relation to studies reported in other populations.

Palabras clave : BCR-ABL; LMC; p210; Bolivia; Survival rate.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License